Reg3g Promotes Pancreatic Carcinogenesis in a Murine Model of Chronic Pancreatitis
Authors:
- 17 July 2015
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (12) , 3656-3668
Abstract
Background Regenerating islet-derived 3 (Reg3) is abnormally expressed in several human digestive system diseases, including chronic pancreatitis (CP) and pancreatic cancer (PC). Aim The purpose of this study was to clarify the mechanism of the enhanced expression of Reg3 in inflammation-induced PC. Methods C57BL/6 mice were treated with caerulein for 6 weeks to induce CP and then injected with pReg3g—a lentivirus system encoding for murine Reg3g—accompanied by dimethylbenzanthracene to induce PC. We detected pancreatic histopathological characteristics, tumor-related gene expression, inflammation-associated pathway activation, serum biochemical indicators, and immunological cell activities. Results The mice that developed CP after caerulein treatment were marked by pronounced histologic lesions, elevated serum amylase levels, and activation of inflammation-related pathways. Mice given a high dose of pReg3g developed PC by 16 weeks, with recognizable tumors in the pancreas. While, both the low and high doses of pReg3g produced higher transcription of c-fos, k-ras, cytokeratin-19, and proliferating cell nuclear antigen, and a lower expression of caspase-3 compared to pNEG controls. Additionally, the higher dose of pReg3g increased the expressions of pSTAT3, NFκB (p65), and SOCS3 methylation during PC development. In addition, mice treated with pReg3g displayed higher levels of serum IL10 and TGFβ and suppressed T lymphocyte proliferation and DC function. Conclusion The comprehensive analysis suggests enhanced Reg3g expression exacerbates PC in inflammation-associated cancer progression. Reg3g appears to promote CP-related PC in mice through multiple mechanisms, involving enhanced transcription of pancreatic tumor markers, repression of anti-tumor immunity, and activation of STAT3/p65 signal transduction pathways.Keywords
Funding Information
- National Natural Science Foundation of China (91229114, 81273521)
This publication has 47 references indexed in Scilit:
- iNOS Expression in CD4+ T Cells Limits Treg Induction by Repressing TGFβ1: Combined iNOS Inhibition and Treg Depletion Unmask Endogenous Antitumor ImmunityClinical Cancer Research, 2014
- STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models.2014
- Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumoursBritish Journal of Cancer, 2014
- SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM PatientsPLOS ONE, 2014
- Discrimination between Adenocarcinoma and Normal Pancreatic Ductal Fluid by Proteomic and Glycomic AnalysisJournal of Proteome Research, 2013
- Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPsJournal of Cell Biology, 2013
- Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in miceBiomedicine & Pharmacotherapy, 2012
- Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in miceCancer Science, 2006
- The v-Rel Oncoprotein Complexes with New Rel- and RelA-Related Proteins in Transformed CellsVirology, 1995
- A novel gene (HIP) activated in human primary liver cancer.1992